ARCA biopharma, Inc.

ABIO | $3.67 6.38% 5.99% 210K

(0.0% 1d) (99.4% 1m) (76.0% 1y) (0.0% 2d) (0.0% 3d) (7.5% 7d) (-68.15% volume)
Earnings Calendar:
Market Cap: $ 53,219,195
http://www.arcabiopharma.com
Sec Filling | Patents | 13 employees

(US) ARCA biopharma, Inc. is a biopharmaceutical company, which develops genetically targeted therapies for heart failure and other cardiovascular diseases. The company engages in cardiovascular pathophysiology, molecular genetics and clinical development. Its product candidate, Gencaro is a pharmacologic beta-blocker and mild vasodilator, which is developed for the treatment of chronic heart failure and other indications. The company was founded by Michael R. Bristow and Christopher David Ozeroff in 1992 and is headquartered in Westminster, CO.

cardiovascular heart genetic treatment

add to watch list Paper trade email alert is off

Press-releases

INVESTIGATION: The M&A Class Action Firm Announces an Investigation of ChampionX Corp. - CHX
Published: 2024-04-10 (Crawled : 01:00) - prnewswire.com
ABIO | $3.67 6.38% 5.99% 210K

Health Technology

| 12.01% | O: 1.62% H: 1.92% C: 0.32%

STOCKHOLDER INVESTIGATION: The M&A Class Action Firm Announces an Investigation of Kintara Biopharma, Inc. - KTRA
Published: 2024-04-10 (Crawled : 01:00) - prnewswire.com
SWAV | $328.41 -0.06% -0.06% 890K

Health Technology

| 0.38% | O: -0.32% H: 1.09% C: 1.02%
KTRA | $0.1309 14.52% 12.68% 7.5M

Distribution Services

| -17.54% | O: -2.17% H: 0.15% C: -1.69%
ABIO | $3.67 6.38% 5.99% 210K

Health Technology

| 12.01% | O: 1.62% H: 1.92% C: 0.32%

Kuehn Law Encourages KTRA, ABIO, SWAV, and NS Investors to Contact Law Firm
Published: 2024-04-05 (Crawled : 18:00) - prnewswire.com
SUN | $56.61 1.27% 0.0% 270K

Distribution Services

| -5.24% | O: 0.0% H: 0.14% C: -1.49%
NS | $22.71 1.93% 0.0% 420K

Distribution Services

| -2.96% | O: -0.44% H: 0.96% C: -0.09%
JNJ | News | $149.56 0.3% 0.0% 9.1M

Health Technology

| -4.04% | O: -1.84% H: 0.0% C: 0.0%
SWAV | $328.41 -0.06% -0.06% 890K

Health Technology

| 2.17% | O: 1.21% H: 0.65% C: 0.25%
KTRA | $0.1309 14.52% 12.68% 7.5M

Distribution Services

| -23.45% | O: -13.08% H: 8.09% C: 4.16%
ABIO | $3.67 6.38% 5.99% 210K

Health Technology

| 12.01% | O: -3.9% H: 7.09% C: 4.39%

ARCA biopharma Announces 2023 Financial Results
Published: 2024-02-01 (Crawled : 22:00) - globenewswire.com
ABIO | $3.67 6.38% 5.99% 210K

Health Technology

| 119.05% | O: -0.32% H: 5.1% C: 3.18%
biopharma financial results

ARCA biopharma Announces Third Quarter 2023 Financial Results
Published: 2023-10-18 (Crawled : 20:00) - globenewswire.com
ABIO | $3.67 6.38% 5.99% 210K

Health Technology

| 69.12% | O: -0.88% H: 0.89% C: 0.39%
biopharma financial results

Global Aptamers Market Landscape 2023-2030: Diagnostics Segment Set for Rapid Expansion, North America Holds Key Position
Published: 2023-08-22 (Crawled : 18:00) - prnewswire.com
ABIO | $3.67 6.38% 5.99% 210K

Health Technology

| 68.29% | O: -0.49% H: 1.47% C: 0.98%
america rapid global set diagnostics market

ARCA biopharma Announces Second Quarter 2023 Financial Results
Published: 2023-07-21 (Crawled : 20:00) - globenewswire.com
ABIO | $3.67 6.38% 5.99% 210K

Health Technology

| Email alert Add to watchlist
biopharma financial results

ARCA biopharma Announces First Quarter 2023 Financial Results
Published: 2023-04-24 (Crawled : 21:00) - globenewswire.com
ABIO | $3.67 6.38% 5.99% 210K

Health Technology

| 76.02% | O: 0.0% H: 1.21% C: 0.0%
biopharma financial results

ARCA biopharma Announces Third Quarter 2022 Financial Results
Published: 2022-10-28 (Crawled : 21:00) - globenewswire.com
ABIO | $3.67 6.38% 5.99% 210K

Health Technology

| Email alert Add to watchlist
biopharma financial results